Justin Albani
Senior Director, Imaging Services
Education: Bachelor's of Science in Natural Science; Nuclear Medicine Technology, Worcester State College
Years of Experience: 11+ years
Location: New Haven, CT
Brian Avants
Ph.D. | Senior Director, Machine Learning
Education: Ph.D. in Bioengineering, University of Pennsylvania
Years of Experience: 20+ years
Location: Boston, MA
As an interdisciplinary scientist with a focus on neuro MR, Dr. Brian Avants has broadly explored the synergies between machine learning, brain mapping and mathematical modeling. Dr. Avants utilizes this expertise in developing computational and algorithmic advances to enhance Invicro’s imaging and data analytics platform.
Lino Becerra
Ph.D. | Vice President, MRI
Education: Ph.D. in Physics, University of Illinois
Years of Experience: 25+ years
Location: Boston, MA
Dr. Lino Becerra serves as Vice President of MRI to further consolidate and expand Invicro's capabilities to support studies utilizing MRI techniques from preclinical to clinical trials. Previously, Dr. Becerra was the Co-Director for The Center for Pain and the Brain at Harvard Medical School as well as being a faculty member for over 20 years. He has worked extensively in neuroimaging applications in neurological conditions. He Co-Founded Descartes Therapeutics Inc., a biotech company that was dedicated to the development of drugs for chronic pain and was Co-Director of the Imaging Consortium for Drug Development, which was formed by Harvard, McLean Hospital, Massachusetts General Hospital, Merck, Eli Lilly and Sepracor Pharmaceuticals.
Karen Briley
Ph.D. | Associate Director, Discovery Research
Education: Ph.D. in Medical Physics, University of Uppsala
Years of Experience: 34+ years
Location: Boston, MA
Dr. Karen Briley has worked in pre-clinical translational imaging for over 30 years. Indication areas include cardiovascular, gastrointestinal, NASH, and other inflammatory diseases.
Cristian Constantinescu
Ph.D. | Associate Director of Translational Research
Education: Ph.D. in Biomedical Engineering, Purdue University
Years of Experience: 14+ years
Location: New Haven, CT
Dr. Cristian Constantinescu has been with Invicro since 2014, serving as Associate Director of Translational Research, specializing in image analysis and kinetic modeling of PET\SPECT data as well as managing image analysis projects in non-human primates and early clinical space.
Hemi Dimant
Ph.D. | Director of Applications
Education:
Ph.D. in Biotechnology , Tel-Aviv University
Location: Boston, MA
Years of Experience: 15+ years
Dr. Hemi Dimant is an expert in molecular imaging for preclinical drug discovery, with extensive experience in designing, managing and supporting drug discovery research for pharma and biotech companies.
Having worked in and with startups and early-stage companies, Dr. Dimant brings value in designing proof-of-concept pilot studies.
Howard Dobson
DV.Sc. | Senior Director, Discovery and Preclinical Services
Education:
DV.Sc. in Veterinary Radiology, University of Guelph
Location: Boston, MA
Years of Experience: 44+ years
Dr. Howard Dobson has a broad ranging career in imaging research, both as a clinical veterinary radiologist and has spent the last 15 years in contract research.
Natalie Ertl
Clinical Imaging Research Assistant
Education: M.Sc., University of Bristol
Years of Experience: 3+ years
Location: London, UK
Natalie has recently started a Ph.D. in investigating brain responses in Hypoactive Sexual Desire Disorder (HSDD).
Zhen Fan
Ph.D. | Senior PET Modeller
Education: Ph.D. in PET Modelling and Neuroimaging, Imperial College London
Years of Experience: 10+ years
Location: London, UK
Dr. Zhen Fan works as a PET Modeller at Invicro. Prior to this, she earned her Ph.D. in neuroimaging modelling while working as an imaging data researcher at Imperial College London. Dr. Fan has over 10 years of experience working with PET/MRI imaging analysis in human and preclinical trials.
Denise Ferraiolo
Senior Vice President, Clinical Operations
Education: Bachelor of Arts in Psychology, Southern CT State University
Years of Experience: 20+ years
Location: New Haven, CT
Ms. Denise Ferraiolo has 20+ years of experience in the clinical imaging space, managing Ph 1-3 clinical imaging trials with a focus in CNS/Neurodegeneration. Specifically, she has spent her career growing with the industry, guiding imaging operations through new innovations.
Roger Gunn
Ph.D. | Chief Scientific Officer
Education: Ph.D. in Applied Mathematics, Warwick University
Years of Experience: 30+ years
Location: London, UK
Dr. Roger Gunn is an international expert in PET neuroimaging, with 30 years of experience designing and analyzing imaging studies for disease understanding and drug development. Dr. Gunn is also a Professor of Molecular Neuroimaging at Imperial College London and has published over 200 peer-reviewed papers in the field of imaging with an H-Index of 65.
Edward Hogan
Chief Operating Officer
Education: M.S. in Electrical Engineering, Tufts University
Years of Experience: 28+ years
Location: Boston, MA
Mr. Edward Hogan has over 28 years of experience in clinical research, managing and executing phase I-IV imaging trials in both the pharmaceutical and CRO space. He brings more than 19 years of experience in managing clinical operations, including extensive experience in building and leading global cross-functional operations teams, including project, image, data and reader management.
Dustin Kentala
Director, Scientific Services
Education: M.Sc. in Pharmacology, Michigan State University
Years of Experience: 16+ years
Location: Boston, MA
Mr. Dustin Kentala has been working in the CRO industry for 16 years with 11 years as an imaging scientist, study director, or above specializing in in vivo imaging techniques such as, PET, SPECT and CT. In addition, his graduate research focused on ocular drug delivery and pharmacology with specific experience evaluating AAV-mediated gene delivery for inherited retinal diseases.
Amy Knorr
M.D., Ph.D. | Clinical Research Physician
Education: MD, Ph.D., Yale University School of Medicine
Years of Experience: 25+ years
Location: New Haven, CT
Dr. Amy Knorr is excited to return to research in CNS disorders to make a difference by finding treatments for these conditions.
Phillip Kuo
M.D., Ph.D. | Distinguished Scientist
Education:
M.D., Ph.D. University of Virginia
AB Chemistry, Harvard University
Years of Experience: 15+ years
Location: Boston, MA
Dr. Phillip Kuo was a tenured Professor in the Departments of Medical Imaging, Medicine and Biomedical Engineering at the University of Arizona. Beyond his academic work, Dr. Kuo has vast experience as a consultant, reader and speaker for CROs and pharmaceutical companies.
Dr. Kuo has authored over 100 publications and has received numerous grants covering a diverse range of disciplines. Dr. Kuo received his A.B. from Harvard University, M.D. and Ph.D. from the University of Virginia, completed his Internal Medicine Residency at UCLA Medical Center, Diagnostic Radiology Residency at Yale New Haven Hospital and Nuclear Medicine Fellowship at Yale New Haven Hospital.
At Invicro, he supports the design, performance and analysis of clinical trials and also supports regulatory approval and post-approval activities, such as reader training.
Jan Passchier
Ph.D. | Executive Vice President, Global Head of Laboratories and Clinics
Education: Ph.D. in PET Radiochemistry, Groningen University
Years of Experience: 20+ years
Location: London, UK
Dr. Jan Passchier is an expert in radiochemistry applied to imaging and drug development. Dr. Passchier completed a Ph.D. in PET radiochemistry from Groningen University prior to moving to GlaxoSmithKline where he worked closely with project teams to identify and develop novel tool compounds for a large variety of CNS, metabolic and respiratory indications.
Dr. Passchier played a significant role in the design and realization of the GlaxoSmithKline Clinical Imaging Centre where he headed the chemistry group. Following the spinout of the centre to Imanova Ltd, now part of Invicro, he took on the overall operational responsibility for the business.
Dr. Passchier has a keen interest and deep understanding of the application of molecular imaging to disease understanding and drug development.
Ryan Petrulli
Ph.D. | Associate Director, Image Analysis
Education: Ph.D. in Biomedical Engineering, Yale University
Years of Experience: 3+ years
Location: New Haven, CT
Christophe Plisson
Ph.D. | Head of Preclinical Sciences
Education: Ph.D. in Organic Chemistry, University of Orleans
Years of Experience: 15+ years
Location: London, UK
Dr. Christophe Plisson started working in the field of PET imaging at the University of Emory in 2001. He joined GlaxoSmithKline in 2004 where he worked on PET tool compound discovery and PET chemistry support across the drug development portfolio. He also had an honorary position of assistant professor at the University of Columbia. Dr. Plisson has been with Invicro since 2011 and currently holds the position as Head of Preclinical Services, overseeing R&D PET chemistry and preclinical PET imaging activities.
Eugenii (Ilan) Rabiner
M.D. | Executive Vice President of Translational Applications
Education: MBBCh - University of the Witwatersrand, FCPsych SA - South African College of Psychiatrists
Years of Experience: 30+ years
Location: London, UK
Trained as a psychiatrist, Dr. Ilan Rabiner moved into research in PET imaging and subsequently drug development. He has spent the last 25 years working in the drug development industry and academia.
Gaia Rizzo
Ph.D. | Associate Director, Oncology Image Analysis
Education: Ph.D. in Information Engineering/Specialization in Bioengineering, University of Padova
Years of Experience: 14+ years
Location: London, UK
David S. Russell
M.D., Ph.D. | Senior Medical Director
Education: M.D., Cornell University Medical College, Ph.D. in Molecular Biology, Cornell, Sloan-Kettering Institute
Years of Experience: 25+ years
Location: New Haven, CT
As the Senior Medical Director, Dr. David S. Russell has been involved in the design and implementation of clinical trials and served as the PI for dozens of trials concerning neurological and non-neurological diseases, as well as with healthy volunteers. He is a neurologist, neurodegenerative diseases specialist, molecular biologist, and former Director of the Yale Neurodegenerative Disorders Clinic.
Nick Sandella
Director | Imaging Services Support
Education: Associates of Applied Science, Nuclear Medicine Technology, Gateway Community Technical College
Years of Experience: 25+ years
Location: New Haven, CT
Christine Sandiego
Ph.D. | Senior Scientist, Translational Research
Education: Ph.D. in Biomedical Engineering, Yale University
Years of Experience: 15+ years
Location: New Haven, CT
Dr. Christine Sandiego has been at Invicro since 2015 with expertise in kinetic modeling and analysis of positron emission tomography (PET) brain data. She is a scientific lead on the translational research team for pre-clinical and early clinical PET studies, helping to support our sponsors’ drug development programs for neurodegenerative diseases.
Graham Searle
Ph.D. | Head of PET Analysis
Education: Ph.D. in Mathematical Modelling, The University of Warwick
Years of Experience: 19+ years
Location: London, UK
Dr. Graham Searle has over 15 years of experience in the development and application of mathematical models for human imaging data. His career has focused on the use of PET imaging in drug development, and the development and implementation of tools for PET data analysis within the context of the pharmaceutical industry.
Rachel Stewart
Ph.D. | Senior Director, Discovery Research
Education: Ph.D. in Biomedical Engineering, Boston University
Years of Experience: 8+ years
Location: Boston, MA
Dr. Rachel Stewart's background is in musculoskeletal and rare disease imaging and orthopedic biomechanics.
Matt Wall
Ph.D. | Senior Imaging Scientist
Education: Ph.D. in Cognitive and Brain Sciences, University of Cambridge
Years of Experience: 20+ years
Location: London, UK
Dr. Matt Wall earned his Ph.D. in Psychology with a post-doctoral focus in psychophysics. Dr. Wall's day-to-day work blends neuroscience and MRI methodology, with a specialty in pharmacology.
Xue Wang
Ph.D. | Senior Scientist, MRI
Education: Ph.D. in Biomedical Engineering, University of Kentucky
Years of Experience: 15+ years
Location: Boston, MA
Lisa Wells
Ph.D. | Head of CNS Discovery Operations
Education: Ph.D. in Neuropharmacology, University of Surrey
Years of Experience: 15+ years
Location: London, UK
After studying in the fields of Medical Biochemistry and Neuropharmacology, Dr. Lisa Wells left academia to join the field of nuclear imaging, taking a role at GSK's Clinical Imaging Center. Later transitioning to Head of Biology at Imanova, Dr. Wells now uses her knowledge of the pharmaceutical industry to lead the global discovery CNS Applications at Invicro.
Ken Zasadny
Ph.D. | Director, Research Programs & Translational Imaging
Education: Ph.D. in Nuclear Engineering, University of Michigan
Years of Experience: 31+ years
Location: Boston, MA
Dr. Ken Zasadny has a mix of academia and pharmaceutical industry experience. His career focus has been on quantitative molecular imaging by PET and SPECT for diagnostic and therapeutic applications.